News and Trends 31 Mar 2023Destiny Pharma gel reduces nasal staph in surgery patients Destiny Pharma has revealed data showing its drug reduced Staphylococcus aureus in the nasal passage of pre-op cardiac surgery patients.… March 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored by MC Services 10 Mar 2023Meet some of the biotechs attending Bio-Europe Spring 2023 As Bio-Europe Spring 2023 is set to take place from March 20 to March 22 in Basel, Switzerland, a budding… March 10, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 15 Nov 2022Destiny Pharma’s XF-73 dermal infection project advances to safety study The second of two planned preclinical safety studies has started for Destiny Pharma’s XF-73 dermal formulation. The company announced the… November 15, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jul 2022Good news for Destiny Pharma’s nasal gel to combat life-threatening infections Clinical stage biotech company, Destiny Pharma, announced today (July 19) a positive update from the U.S. Food and Drug Administration… July 19, 2022 - 5 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jul 2022Treatments set to improve for lethal lung disease and ulcers following drug synergy data revelation New data has been published today (July 7) evidencing findings that could lead to better treatment for people with lethal… July 7, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email